Cargando…
Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3
Venezuelan equine encephalitis virus (VEEV) is a new world alphavirus and a category B select agent. Currently, no FDA-approved vaccines or therapeutics are available to treat VEEV exposure and resultant disease manifestations. The C-terminus of the VEEV non-structural protein 3 (nsP3) facilitates c...
Autores principales: | Bakovic, Allison, Bhalla, Nishank, Alem, Farhang, Campbell, Catherine, Zhou, Weidong, Narayanan, Aarthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402862/ https://www.ncbi.nlm.nih.gov/pubmed/34452398 http://dx.doi.org/10.3390/v13081533 |
Ejemplares similares
-
Inhibition of Venezuelan Equine Encephalitis Virus Using Small Interfering RNAs
por: Haikerwal, Amrita, et al.
Publicado: (2022) -
Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection
por: Risner, Kenneth, et al.
Publicado: (2019) -
Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
por: Ahmed, Aslaa, et al.
Publicado: (2020) -
Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis
por: Bakovic, Allison, et al.
Publicado: (2020) -
The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection
por: Yao, Zhiyuan, et al.
Publicado: (2021)